PMV Pharmaceuticals Executives Sell Shares at $1.06/Share on July 1, 2025
ByAinvest
Thursday, Jul 3, 2025 7:54 pm ET1min read
PMVP--
PMV Pharmaceuticals, Inc. (PMVP) recently disclosed that Chief Financial Officer Carulli Michael sold 28,249 shares at a price of $1.06 per share on July 1, 2025. Additionally, Chief Development Officer Jalota Deepika sold 33,065 shares at the same price point on the same day. Furthermore, Director, President and CEO Mack David Henry sold 58,411 shares at $1.06 per share, while General Counsel & COO Ticktin Robert sold 23,151 shares at the same price on July 1, 2025.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet